Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0001773751-24-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-16 | 2024-02-14+ | HIMS | Boughton Soleil | CLO | M - OptEx | $2.43 | +23.1K | 171.5K | +16% | +$56.1K |
| DM | 2024-02-16 | 2024-02-14+ | HIMS | Boughton Soleil | CLO | S - Sale+OE | $10.01 | -23.1K | 154.3K | -13% | -$231.0K |
| DM | 2024-02-16 | 2024-02-14+ | HIMS | Boughton Soleil | CLO | M - OptEx | $0.00 | -23.1K | 177.4K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-15 | M | A | 5,972 | $2.43 | 160,317 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-02-14 | S | D | 17,109 | $10.00 | 154,345 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.00 - $10.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2024-02-14 | M | A | 17,109 | $2.43 | 171,454 | D | — | — | |
| 4 | Common | Class A Common Stock | 2024-02-15 | S | D | 5,972 | $10.04 | 154,345 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.00 - $10.11. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to buy) | 2024-02-14 | M | D | 17,109 | $0.00 | 183,362 | D | $2.43 · — to 2030-05-12 | 17,109 Class A Common Stock | (F4) The option award vests over a four year period, with 1/48 of the shares subject to the stock option vesting when the Reporting Person completes each month of continuous Service beginning February 12, 2020. 100% of the shares subject to the option award are fully vested. |
| 6 | Derivative | Stock Option (right to buy) | 2024-02-15 | M | D | 5,972 | $0.00 | 177,390 | D | $2.43 · — to 2030-05-12 | 5,972 Class A Common Stock | (F4) The option award vests over a four year period, with 1/48 of the shares subject to the stock option vesting when the Reporting Person completes each month of continuous Service beginning February 12, 2020. 100% of the shares subject to the option award are fully vested. |